LS
BMY icon

Leelyn Smith’s Bristol-Myers Squibb BMY Stock Holding History

Leelyn Smith’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
59,312
+1,221
+2% +$70.1K 0.42% 67
2026
Q1 		$3.52M Buy
58,091
+457
+0.8% +$26.6K 0.49% 56
2025
Q4 		$3.11M Buy
57,634
+2,630
+5% +$127K 0.45% 57
2025
Q3 		$2.48M Buy
55,004
+5,956
+12% +$278K 0.37% 76
2025
Q2 		$2.27M Buy
49,048
+1,781
+4% +$87.4K 0.37% 76
2025
Q1 		$2.88M Sell
47,267
-432
-0.9% -$25.2K 0.51% 53
2024
Q4 		$2.7M Buy
47,699
+215
+0.5% +$12K 0.48% 52
2024
Q3 		$2.46M Buy
47,484
+3,977
+9% +$187K 0.44% 67
2024
Q2 		$1.81M Buy
43,507
+4,982
+13% +$223K 0.35% 77
2024
Q1 		$2.09M Buy
38,525
+1,681
+5% +$85.6K 0.42% 68
2023
Q4 		$1.89M Buy
36,844
+605
+2% +$31.8K 0.41% 65
2023
Q3 		$2.1M Buy
36,239
+651
+2% +$39.9K 0.51% 56
2023
Q2 		$2.28M Sell
35,588
-1,447
-4% -$97K 0.55% 54
2023
Q1 		$2.57M Buy
37,035
+553
+2% +$39K 0.66% 46
2022
Q4 		$2.62M Buy
36,482
+2,142
+6% +$162K 0.72% 43
2022
Q3 		$2.44M Hold
34,340
– – 0.84% 29
2022
Q2 		$2.64M Buy
34,340
+1,117
+3% +$85.1K 0.69% 40
2022
Q1 		$2.43M Buy
33,223
+973
+3% +$65.3K 0.63% 44
2021
Q4 		$2.01M Sell
32,250
-425
-1% -$24.9K 0.54% 53
2021
Q3 		$1.93M Buy
32,675
+8
+0% +$527 0.56% 51
2021
Q2 		$2.18M Buy
32,667
+510
+2% +$33.3K 0.64% 45
2021
Q1 		$2.03M Buy
32,157
+878
+3% +$54.6K 0.6% 48
2020
Q4 		$1.94M Sell
31,279
-449
-1% -$27.6K 0.62% 44
2020
Q3 		$1.91M Buy
31,728
+30,808
+3,349% +$1.85M 0.68% 35
2020
Q2 		$1.9M Sell
920
-32,218
-97% -$1.93M 0.78% 29
2020
Q1 		$1.85M Buy
33,138
+2,151
+7% +$131K 0.99% 21
2019
Q4 		$1.99K Buy
+30,987
New +$1.77M 0.96% 18

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Leelyn Smith's BMY Position: Q2 2026 in Review

Leelyn Smith increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, buying an estimated $70.1K and bringing the position to 59,312 shares worth $3.42M. The position accounts for 0.42% of the portfolio, ranked #67.

Leelyn Smith first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.52M in Q1 2026. 874 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Leelyn Smith held 59,312 shares of Bristol-Myers Squibb worth $3.42M as of Q2 2026.
  • Leelyn Smith bought 1,221 Bristol-Myers Squibb shares in Q2 2026, an estimated $70.1K.
  • Bristol-Myers Squibb made up 0.42% of Leelyn Smith's portfolio in Q2 2026, its #67 holding.
  • Leelyn Smith first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Leelyn Smith's Bristol-Myers Squibb position peaked at $3.52M in Q1 2026.
  • 874 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.